First Allied Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,854
| Closed | -$229K | – | 1183 |
|
|
2020
Q2 | $229K | Buy |
+1,854
| New | +$229K | 0.01% | 937 |
|
|
2019
Q3 | – | Sell |
-3,087
| Closed | -$264K | – | 1636 |
|
|
2019
Q2 | $264K | Sell |
3,087
-97
| -3% | -$8.3K | 0.01% | 949 |
|
|
2019
Q1 | $281K | Buy |
+3,184
| New | +$281K | 0.01% | 899 |
|
|
2018
Q1 | – | Sell |
-2,533
| Closed | -$224K | – | 1183 |
|
|
2017
Q4 | $224K | Buy |
2,533
+100
| +4% | +$8.84K | 0.01% | 995 |
|
|
2017
Q3 | $229K | Buy |
2,433
+18
| +0.7% | +$1.69K | 0.01% | 941 |
|
|
2017
Q2 | $225K | Hold |
2,415
| – | – | 0.01% | 973 |
|
|
2017
Q1 | $212K | Sell |
2,415
-102
| -4% | -$8.95K | 0.01% | 963 |
|
|
2016
Q4 | $209K | Sell |
2,517
-390
| -13% | -$32.4K | 0.01% | 970 |
|
|
2016
Q3 | $269K | Buy |
+2,907
| New | +$269K | 0.01% | 793 |
|